In summary, this study demonstrated that SETD6 is upregulated in LUAD tumor tissues, and its overexpression significantly correlates with higher rates of regional lymph node metastasis and poor prognosis in patients with LUAD, which indicated that SETD6 has a potential role in promoting LUAD development. The gene discussed is SETD6; the disease is neoplasm.